Korro Bio (KRRO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Korro Bio (KRRO) is Moderate Underperform.

The composite score behind that read is -0.30, weighing +0.58 of bullish evidence against -0.41 bearish.

Korro Bio last closed at $9.97, +3.42% on the session.

Against the IVW growth benchmark the position is +2.50% over the forecast window.

The read is built from 12 underlying insights — 1 bullish and 11 bearish.

Agreement across those insights is 92%.

16 graded predictions for KRRO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Korro Bio in the 9th percentile on return on equity, where 100 is best.

Korro Bio is classified under Health Care / Biotechnology, with a market capitalisation of $141.96M.

StockMap tracks Korro Bio as the 246th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Korro Bio ranks 254th of 344 in the group, against a group median of -0.21.